Central retinal vein occlusion: The therapeutic options

Canadian Journal of Ophthalmology

Volumn 42, Issue 2, 2007, Pages 193-195

  Madhusudhana, Krishnappa C ^a   Newsom, Richard S B ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; DEXAMETHASONE; POSURDEX; STEROID; TRIAMCINOLONE; UNCLASSIFIED DRUG;

ANASTOMOSIS; CATARACT; CENTRAL RETINA VEIN OCCLUSION; CLINICAL TRIAL; DRUG SAFETY; EDITORIAL; FIBRINOLYSIS; HUMAN; INTRAOCULAR PRESSURE; LASER COAGULATION; LOW DRUG DOSE; RADIAL OPTIC NEUROTOMY; RETINA MACULA EDEMA; RETINA NEOVASCULARIZATION; VISUAL IMPAIRMENT; VITRECTOMY;

EID: 34248212237     PISSN: 00084182     EISSN: 17153360     Source Type: Journal    
DOI: 10.3129/can.j.ophthalmol.i07-011     Document Type: Editorial

References (29)

1. Hayreh SS. Management of central retinal vein occlusion. Ophthalmologica 2003;217:167-88.
2. The Central Vein Occlusion Study Group. Natural history and clinical management of central retinal vein occlusion. Arch Ophthalmol 1997;115:486-91.
3. Manivannan A, Plskova J, Farrow A, Mckay S, Sharp PF, Forrester JV. Ultra-wide-field fluorescein angiography of the ocular fundus. Am J Ophthalmol 2005;140:525-7.
4. The Central Vein Occlusion Study Group. Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion. The Central Vein Occlusion Study Group M report. Ophthalmology 1995;102:1425-33.
5. Rosenfeld PJ, Fung AE, Puliafito CA. Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for macular edema from central retinal vein occlusion. Ophthalmic Surg Lasers Imaging 2005;36:336-9.
6. Iturralde D, Spaide RF, Meyerle CB, et al. Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study. Retina 2006; 26:279-84.
7. Conti SM, Kertes PJ. The use of intravitreal corticosteroids, evidence-based and otherwise. Curr Opin Ophthalmol 2006; 17:235-44.
8. Konstantopoulos A, Williams CP, Newsom RS, LufF AJ. Ocular morbidity associated with intravitreal triamcinolone acetonide. Eye 2006 May 19; [Epub ahead of print].
9. The Standard Care Vs. COrticosteroid for REtinal Vein Occlusion (SCORE) Study. Available: http://www.clinicaltrials.gov (accessed 2007 Jan 17).
10. Hvarfner C, Larsson J. Vitrectomy for non-ischaemic macular oedema in retinal vein occlusion. Acta Ophthalmol Scand 2006;84:812-4.
11. Hayreh SS, Klugman MR, Podhajsky P, Servais GE, Perkins ES. Argon laser panretinal photocoagulation in ischemic central retinal vein occlusion. A 10-year prospective study. Graefes Arch Clin Exp Ophthalmol 1990;228:281-96.
12. The Central Vein Occlusion Study Group. A randomized clinical trial of early panretinal photocoagulation for ischemic central vein occlusion. The Central Vein Occlusion Study Group N report. Ophthalmology 1995;102:1434-44.
13. Retinal Vein Occlusion Guidelines. London, UK: Royal College of Ophthalmologists; March 2004.
14. Grisanti S, Biester S, Peters S, Tatar O, Ziemssen F, Bartz-Schmidt KU; Tuebingen Bevacizumab Study Group. Intracameral bevacizumab for iris rubeosis. Am J Ophthalmol 2006;142:158-60.
15. Kahook MY, Schuman JS, Noecker RJ. Intravitreal bevacizumab in a patient with neovascular glaucoma. Ophthalmic Surg Lasers Imaging 2006;37:144-6.
16. Hansen LL, Wiek J, Wiederholt M. A randomised prospective study of treatment of non-ischaemic central retinal vein occlusion by isovolaemic haemodilution. Br J Ophthalmol 1989; 73:895-9.
17. Wolf S, Arend O, Bertram B, et al. Hemodilution therapy in central retinal vein occlusion. One-year results of a prospective randomized study. Graefes Arch Clin Exp Ophthalmol 1994; 232:33-9.
18. Glacet-Bernard A, Zourdani A, Milhoub M, Maraqua N, Coscas G, Soubrane G. Effect of isovolemic hemodilution in central retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2001;239:909-14.
19. Opremcak EM, Bruce RA, Lomeo MD, Ridenour CD, Letson AD, Rehmar AJ. Radial optic neurotomy for central retinal vein occlusion: a retrospective pilot study of 11 consecutive cases. Retina 2001;21:408-15.
20. Opremcak EM, Rehmar AJ, Ridenour CD, Kurz DE. Radial optic neurotomy for central retinal vein occlusion: 117 consecutive cases. Retina 2006;26:297-305.
21. Garcia-Arumi J, Boixadera A, Martinez-Castillo V, Montolio M, Verdugo A, Corcostegui B. Radial optic neurotomy in central retinal vein occlusion: comparison of outcome in younger vs older patients. Am J Ophthalmol 2007;143: 134-40.
22. Martinez-Jardon CS, Meza-de Regil A, Dalma-Weiszhausz J, et al. Radial optic neurotomy for ischaemic central vein occlusion. Br J Ophthalmol 2005;89:558-61.
23. Zambarakji HJ, Ghazi-Nouri S, Schadt M, Bunce C, Hykin PG, Charteris DG. Vitrectomy and radial optic neurotomy for central retinal vein occlusion: effects on visual acuity and macular anatomy. Graefes Arch Clin Exp Ophthalmol 2005; 243:397-405.
24. Lahey JM, Fong DS, Kearney J. Intravitreal tissue plasminogen activator for acute central retinal vein occlusion. Ophthalmic Surg Lasers 1999;30:427-34.
25. Glacet-Bernard A, Kuhn D, Vine AK, Oubraham H, Coscas G, Soubrane G. Treatment of recent onset central retinal vein occlusion with intravitreal tissue plasminogen activator: a pilot study. Br J Ophthalmol 2000;84:609-13.
26. Bynoe LA, Hutchins RK, Lazarus HS, Friedberg MA. Retinal endovascular surgery for central retinal vein occlusion: initial experience of four surgeons. Retina 2005;25:625-32.
27. Feltgen N, Junker B, Agostini H, Hansen LL. Retinal endovascular lysis in ischemic central retinal vein occlusion: one-year results of a pilot study. Ophthalmology 2006 Nov 29; [Epub ahead of print].
28. McAllister IL, Douglas JP, Constable IJ, Yu DY. Laser-induced chorioretinal venous anastomosis for nonischemic central retinal vein occlusion: evaluation of the complications and their risk factors. Am J Ophthalmol 1998;126:219-29.
29. Mirshahi A, Roohipoor R, Lashay A, Mohammadi SF, Mansouri MR. Surgical induction of chorioretinal venous anastomosis in ischaemic central retinal vein occlusion: a non-randomised controlled clinical trial. Br J Ophthalmol 2005; 89:64-9.